CLINICAL_TRIALS trial_result · 2024-10-04

Clinical Trial Update: A Study of LY3002813 in Participants With Alzheimer's Disease [Phase 1]

The update reports completion of a Phase 1 study of LY3002813 in participants with Alzheimer disease and indicates that results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-10-04